EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucoadhesive micelles for ophthalmic drug delivery

Taylor Goostrey, Mitchell Ross, Karim Soliman, Lindsay Sheardown, Heather Sheardown iD

Journal of Biomaterials Applications · 2026

DOI: 10.1177/08853282251386004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2026. Verfasst von Taylor Goostrey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, McMaster University, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Micelles, Ophthalmic Solutions, Cyclosporine, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Ontario Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common formulation for treating ocular conditions is topical eyedrops, despite their well-documented inefficiency. In this study, mucoadhesive nano-micelles were developed to overcome the poor efficacy of topical eyedrops in the treatment of dry eye disease. The micelles contained a pre-activated thiomer capable of releasing mucolytic N-acetylcysteine upon covalent disulfide exchange with the natural mucus layer which covers the surface of the eye. The micelles, approximately 70 nm in diameter, were shown to be mucoadhesive through zeta potential analysis. The critical micelle concentration was determined to be 217 mg/L using the pyrene fluorescence method. The core of the micelles was loaded with cyclosporine A, displaying a greater than 90% entrapment efficiency, and yielding sustained release of approximately 57% over 10 days. The cellular response to the micelles was tested with human corneal epithelial cells by MTT assay and Live/Dead staining. It was found that lower concentrations of the amphiphilic polymer resulted in greater cellular viability and in all cases, viability increased from 24 to 48 h following treatment. Overall, these mucoadhesive systems have potential to provide more efficacious treatment of anterior segment ocular conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesOphthalmic SolutionsCyclosporineDrug Delivery SystemsDrug CarriersHumansCell SurvivalAdministration, OphthalmicCell LineEpithelium, CornealAdhesiveness

Stichwörter der Autor:innen

controlled drug releasedry eye diseasemucoadhesionnano-micelles

Substanzen

MicellesOphthalmic SolutionsCyclosporineDrug Carriers

Autor:innen und Institutionen

  • Department of Chemical Engineering, McMaster University, Hamilton, ON, Canada.

ORCID-Profile: Heather Sheardown

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Ontario Research Fund

Zitieren

APA

Goostrey, T., Ross, M., Soliman, K., Sheardown, L., & Sheardown, H. (2026). Mucoadhesive micelles for ophthalmic drug delivery. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251386004

Vancouver

Goostrey T, Ross M, Soliman K, Sheardown L, Sheardown H. Mucoadhesive micelles for ophthalmic drug delivery. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282251386004

BibTeX
@article{Goostrey2026,
  author = {Goostrey, Taylor and Ross, Mitchell and Soliman, Karim and Sheardown, Lindsay and Sheardown, Heather},
  title = {Mucoadhesive micelles for ophthalmic drug delivery},
  journal = {Journal of Biomaterials Applications},
  year = {2026},
  doi = {10.1177/08853282251386004}
}
Kostenlos starten →